SWHR in the News
As part of our mission to improve women’s health and eliminate imbalances in care for women, SWHR serves as a resource on issues related to women’s health and sex differences research. See below for recent news articles citing SWHR insights on women’s health.
If you are a member of the media looking for expert comment on a women’s health topic, please contact SWHR at email@example.com.
Wired, July 9, 2020
SWHR President and CEO Kathryn Schubert discusses possible explanations for why more men than women are dying from COVID-19. Three months into the pandemic, it is still unclear why the novel coronavirus affects women and men differently. This crisis underscores the fact that more research to understand biological sex differences is imperative.
Forbes, June 17, 2020
Drawing on information from SWHR’s sleep health paper, an article in Forbes examines sex differences in sleep disorders. Studies have shown that women are more likely to suffer from certain sleep problems like insomnia.
U.S. News, June 9, 2020
SWHR CEO Kathryn Schubert discusses the importance of including women in medical research in response to a new study shows that although some progress has been made on inclusion of female subjects in research, scientists are still not consistently analyzing data for sex differences, impeding our understanding of how biological differences between women and men influence health and disease.
Mic.com, May 28, 2020
SWHR’s Drs. Lucy Erickson and Melissa Laitner weigh in on the barriers to endometriosis diagnosis and treatment in a recent Mic.com article about Rep. Abby Finkenauer’s experience with the condition and her founding of a new House Endometriosis Caucus.
GenomeWeb, March 16, 2020
Lawmakers introduced a bill that would vastly change oversight for diagnostics and give the FDA explicit authority to regulate tests developed by labs. Former SWHR CEO Dr. Amy M. Miller spoke with GenomeWeb about the VALID Act’s implications.
Glamour, March 5, 2020
Like 1 in 10 women worldwide, Rep. Abby Finkenauer has endometriosis, an often-debilitating gynecological condition that can cause infertility and pelvic pain. Read her story in this Glamour article, which cites SWHR’s paper on gaps in endometriosis research and care and quotes lead author Dr. Suzie As-Sanie.
Long Island Woman, March 2020
SWHR Communications Director Emily Ortman discusses overcoming bias against women in pain management and the need for more funding to research pain conditions that disproportionately affect women like migraine.
The Swaddle, January 25, 2020
An edited excerpt from the new book Pain and Prejudice by Gabrielle Jackson details women’s historical exclusion from research and the harmful results and mentions the role of SWHR in advocating for change.
Mashable, December 18, 2019
A report from the World Economic Forum finds that at the current rate of change, we’ll need to wait another hundred years before achieving global gender parity. To speed things, this article recommends supporting organizations like SWHR that are working to advance women’s interests.
The Guardian, November 13, 2019
Another published excerpt from Gabrielle Jackson’s book Pain and Prejudice mentioning how SWHR teamed up with some U.S. Congress members in order to draw attention to the discrepancies in medical research and the effect on women’s health.
FierceHealthcare, September 16, 2019
This article summarizing the dangers of gender bias in areas of medicine like cardiovascular disease, mental health, and pain conditions quotes SWHR CEO Dr. Amy M. Miller on how women’s pain is often initially dismissed by health care providers.
Oprah Magazine, September 10, 2019
SWHR CEO Dr. Amy M. Miller expresses frustration that not as much attention is given to treating women’s conditions like hot flashes due to menopause as is given to men’s conditions like erectile dysfunction.
New York Post, August 5, 2019
SWHR CEO Dr. Amy M. Miller and Board member Dr. Nieca Goldberg share their women’s health expertise in this article about how the medical field dismissed female health concerns for decades. Goldberg says she often sees women who have had their concerns dismissed by another doctor.
Washington Post, July 29, 2019
SWHR CEO Dr. Amy M. Miller comments on the dismissal and normalization of women’s pelvic pain for this article about disparities in care for chronic pain.
Prevention, July 23, 2019
Sometimes doctors may over-attribute symptoms in middle-age women as related to perimenopause, causing these women to wait longer for diagnoses and treatment of other health conditions. Part of the problem stems from the fact that “Female-only conditions like menopause have long been ignored by scientists,” SWHR’s CEO Dr. Amy M. Miller tells Prevention.
Pharmacy Today, July 2019
Progress has been made over the decades to include women in clinical trials and improve research on women, SWHR CEO Dr. Amy M. Miller explains in this article. Though, research on drug safety and efficacy has not been sufficient for pregnant and breastfeeding women. This article discusses how pharmacists can step in and provide much-needed care to women.
OneZero, May 16, 2019
Scientists have traditionally regarded men as the default patient. “This created a huge gap in knowledge about women’s health and the ways in which women’s biology and health needs differ from men’s,” SWHR CEO Dr. Amy M. Miller explains to OneZero, a new science and technology publication by Medium.
Consumer Reports, May 2, 2019
Doctors are more likely to dismiss pain symptoms based on patients’ race, gender, and age. For women with pelvic pain caused by conditions such as endometriosis and fibroids, they are commonly told their pain is just a normal part of being a woman, SWHR CEO Dr. Amy M. Miller explains.
Reservoir Communications Group, May 1, 2019
We’re in the golden age of biomedical progress, and yet women’s health still presents many mysteries to the scientific community, SWHR Board member Gretta Stone writes in a blog post.
DAME magazine, April 22, 209
When it comes to the differences between men and women, “There’s a lot we don’t know,” SWHR’s Dr. Amy M. Miller says in this article exploring science’s failure to study women’s health. “We only started including women in research 15 or 20 years ago and that means a lot of generic drugs may not have been investigated in women. We don’t know if a drug isn’t as effective in a woman’s body as it is in a man’s.”
Globe and Mail, April 1, 2019
SWHR CEO Dr. Amy M. Miller explains that the knowledge gap around the effects of oral contraceptives is part of a broader historical lack of research into women’s health in general.
Inside Health Policy, March 28, 2019
SWHR CEO Amy M. Miller comments on the VALID Act, noting that its latest product of a years-long effort to draw up FDA regulations in the diagnostics space. She said much of the industry’s hesitation with the discussion draft comes from the relatively new concept of precertification.
Healthline, March 20, 2019
A new study shows women were diagnosed later than men in more than 700 diseases. “When we ask why are there these disparities, I think it’s because we’ve ignored women’s health for so long,” SWHR CEO Dr. Amy M. Miller told Healthline.
GenomeWeb, February 1, 2019
SWHR wrote to the Centers for Medicare & Medicaid Services requesting the agency change its decision to restrict coverage of next-generation sequencing-based testing for hereditary cancer risk. GenomeWeb cited SWHR’s letter expressing concerns that CMS’ guidance will deny women access to tests that could profoundly improve their health outcomes and survival rates.